+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vectura Group plc - logo

Vectura Pharma was established in 1997, and its headquarters are in Chippenham in the U.K. Vectura Group plc researches, develops, and commercializes novel therapeutic products and drug delivery systems for the treatment of airways-related diseases Vectura entered into its first global commercialisation and development agreement with Novartis for NVA237. The company’s marketed products include Ultibro Breezhaler and Seebri Breezhaler for the treatment of chronic obstructive pulmonary disease (COPD).

From
From
From
From
From
Asthma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Asthma Therapeutics - Global Strategic Business Report

  • Report
  • May 2024
  • 194 Pages
  • Global
From
From
Inhalers - Medical Devices Pipeline Assessment, 2019 - Product Thumbnail Image

Inhalers - Medical Devices Pipeline Assessment, 2019

  • Report
  • May 2019
  • 357 Pages
  • Global
From
Asthma Drugs Global Market Report 2024 - Product Thumbnail Image

Asthma Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Global Asthma Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Global Asthma Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 160 Pages
  • Global
From
Cough and Cold Preparations Global Market Report 2024 - Product Thumbnail Image

Cough and Cold Preparations Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
HP (High Potency) APIs Global Market Report 2024 - Product Thumbnail Image

HP (High Potency) APIs Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Loading Indicator